Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-02-19FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Original Application (Lifestar Pharma LLC)
FDA-approved Amitriptyline hydrochloride as a generic product via Original Application by Lifestar Pharma LLC.
-
FDA approval · 2021-02-17FDA Approved: SUMATRIPTAN — Original Application (Florida Pharmaceutical Products, LLC.)
FDA approved the original application for Sumatriptan from Florida Pharmaceutical Products, LLC, authorizing a generic version of the migrai…
-
CLINICAL_TRIALS trial_result · 2021-02-12Clinical Trial Update: Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301) [Phase 3]
Phase 3 trial update reporting safety and tolerability of POD-DHE (INP104) for migraine; results have been posted following completion.
-
FDA approval · 2021-02-10FDA Approved: DEPAKOTE — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental NDA for Depakote (divalproex sodium) submitted by AbbVie Inc.
-
FDA label_change · 2021-02-03FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)
FDA approved a supplemental application for AIMOVIG (erenumab-aooe) filed by Amgen to update the product labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Efficacy and Safety of Nerivio Device for Acute Treatment of Migraine in People With Chronic Migraine [NA]
A completed clinical trial report on the Nerivio device for acute treatment of migraine in people with chronic migraine, with results posted…
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: Efficacy and Safety of Nerivio™ for Acute Treatment of Migraine in People With Chronic Migraine [NA]
Completed clinical trial evaluating the efficacy and safety of Nerivio for acute treatment of migraine in people with chronic migraine.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine [Phase 4]
A Phase 4 trial evaluating the effects of Eletriptan 40 mg on mild versus moderate-to-severe pain in migraine has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory Drugs [Phase 4]
Phase 4 trial update evaluating the safety and efficacy of eletriptan for migraine in patients not adequately treated with NSAIDs.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy [Phase 4]
Phase 4 trial updating the efficacy and safety of eletriptan for treating migraine in patients not satisfied with rizatriptan therapy.
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE [Phase 3]
Phase 3 trial update evaluating efficacy and safety of Zomig Nasal Spray for acute migraine in children aged 6 to 11 years with ongoing open…
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department [Phase 3]
Clinical trial update for intranasal lidocaine to treat pediatric migraine in the emergency department in Phase 3.
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Safety and Efficacy Study in Adult Subjects With Acute Migraines [Phase 3]
Phase 3 safety and efficacy study in adults with acute migraines has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Safety and Efficacy in Adult Subjects With Acute Migraines [Phase 3]
A Phase 3 clinical trial update reports safety and efficacy results in adults with acute migraines (with or without aura).
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Efficacy and Safety of BGG492 in the Treatment of Migraine [Phase 2]
Phase 2 trial update evaluating efficacy and safety of BGG492 for migraine has completed.
-
FDA approval · 2020-12-04FDA Approved: SUMATRIPTAN AND NAPROXEN SODIUM — Supplemental Application (NorthStar RxLLC)
The FDA approved a supplemental application to market a fixed-dose combination of sumatriptan and naproxen sodium for the acute treatment of…
-
FDA approval · 2020-11-24FDA Approved: ELETRIPTAN HYDROBROMIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Eletriptan hydrobromide from Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2020-11-24FDA Approved: ELETRIPTAN HYDROBROMIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Eletriptan hydrobromide from Aurobindo Pharma Limited, authorizing its continued use as a ge…
-
FDA approval · 2020-11-18FDA Approved: TROKENDI XR — Supplemental Application (Supernus Pharmaceuticals, Inc.)
FDA approved a supplemental application for Trokendi XR (topiramate) from Supernus Pharmaceuticals, indicating an update to its labeling.
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Neurologic Signatures of Chronic Pain Disorders [Phase 4]
Phase 4 clinical trial update on neurologic signatures of chronic pain disorders, including chronic pain, chronic migraine, and fibromyalgia…
-
FDA approval · 2020-10-30FDA Approved: VALPROIC ACID — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Valproic Acid submitted by ANI Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2020-10-27Clinical Trial Update: Registry for Migraine - Clinical Core [Phase 4]
A Phase 4 clinical trial update for the Registry for Migraine – Clinical Core, with unknown status.
-
FDA approval · 2020-10-26FDA Approved: NARATRIPTAN — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Naratriptan by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., permitting the sal…
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: Migraine Treatment With Nerivio Migra Neurostimulation Device [NA]
A terminated clinical trial evaluating the Nerivio Migra neurostimulation device for acute migraine has posted results.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Bronx MBCT-Migraine [NA]
A completed clinical trial (NCT02443519) on migraine sponsored by Albert Einstein College of Medicine; results posted in 2020.